GE HealthCare Technologies (GEHC，上涨 0.48%) 预计将于周一宣布以 9.45 亿美元现金收购一家生产用于医学影像程序的放射性物质的制造商。
GE HealthCare Technologies GEHC 0.48%increase; up pointing triangle is expected to announce Monday a $945 million cash purchase of a manufacturer of radioactive substances used in medical-imaging procedures.
这笔交易标志着医疗设备制造商 GE HealthCare 继续进军不断增长的放射性药物市场，该类药物可用于诊断和治疗癌症、心脏病和阿尔茨海默病等疾病。
The deal marks a continued push by medical-equipment maker GE HealthCare into the growing market for radiopharmaceuticals, which have uses for both diagnosing and treating diseases including cancer, heart disease and Alzheimer’s.